High-throughput Screening Market Competitive Landscape And Regional Forecast To 2030
High Throughput Screening (HTS) is an automated drug-discovery process that is typically utilized in the pharmaceutical business. It uses mechanization to identify active compounds, genes, or antibodies in a relatively short time frame. The technique has its use in the initial stages of drug discovery pathway and in toxicology studies. Since HTS enables assaying of a large set of potential biological modulators against a chosen number of defined targets, it has attained the status of being a popular approach to the target validation.
High
Throughput Screening Market Trends was valued at USD 8.2 billion in 2022
and is projected to grow from USD 17.45 Billion in 2023 to USD 112.8 billion by
2030, exhibiting a compound annual growth rate (CAGR) of 5.12% during the
forecast period (2023 - 2030).Mounting investments in the healthcare sector and
the shifting inclination towards high throughput research is pushing the growth
of the market. The HTS market, globally, is largely driven by efficacy &
safety screening, target identification & validation, and monitoring of
cell-based activity. Some of the additional pointers that would support the
growth of the market are the rising drug discovery initiatives by academic and
government institutions, huge acceptance of open innovation models by
pharmaceutical organizations.
Market Segmentation
The market segmentation of High-throughput Screening is
segmented on the following basis: application, product, and end-users.
By application, the market includes Toxicology, Target
Identification, Stem Cell Biology, Primary Screening, and others.
By products, the market comprises consumables, software,
instruments, and others.
By end-users, the market includes pharmaceutical
companies/manufacturers, government organizations, Hospitals and clinics,
research facilities, and others
Regional Analysis
The regional market segmentation of High-throughput
Screening market is divided into North America, Europe, Asia-Pacific, and the
Middle East & Africa.
The North American region is the global geographical market
leader of high-throughput screening and is expected to grow at an impressive
CAGR of XX% during the forecast period. The demanding R&D initiatives
undertaken herein is the major factor that is driving the market growth of this
region. High expenditure in healthcare coupled with substantial investments
from government and private entities for R& purposes are sure to push the
market reach of the North American region.
Europe is the second-largest market and is projected to grow
at a substantially fast-paced CAGR percentage during the forecast period.
Government support and initiatives are some of the major reasons accelerating
the market push of Europe. Additionally, the booming pharmaceutical industry
and a resurging economy are further adding fuel to the market potential.
Asia-Pacific is growing at a rapid scale and is expected to
come out as one of the most lucrative global markets in the forthcoming years.
With over half of the world’s total population residing in this region, it
provides immense growth opportunities for high-throughput screening market. Moreover,
venture capitalists and private equity firms are investing more and more in the
HTS market in nations like India, Japan, and China.
Competitive Analysis:
The report also identifies some of the most prominent
players in the global High-throughput
Screening market Competitive Landscape , which includes Roche
(Switzerland), Agilent Technologies Inc. (US), Beckman Coulter, Inc. (US),
Thermo Fisher Scientific, Inc. (US), Life Technologies Corporation (US), Aurora
Biomed Inc. (Canada), Bio-Rad Laboratories (US), Luminex Corporation (US), and
Sigma-Aldrich Corporation. (US).
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services
Comments
Post a Comment